Copyright
©The Author(s) 2021.
World J Cardiol. Dec 26, 2021; 13(12): 676-694
Published online Dec 26, 2021. doi: 10.4330/wjc.v13.i12.676
Published online Dec 26, 2021. doi: 10.4330/wjc.v13.i12.676
Figure 3 Examples of deleterious cardiovascular pathways associated with hyperphosphatemia and reactive oxygen species.
Adapted from Servier Medical Art, which is licensed under a Creative Commons Attribution 3.0 Unported License. ROS: Reactive oxygen species; NF-κB: Nuclear factor kappa-B.
- Citation: Nashawi M, Ahmed MS, Amin T, Abualfoul M, Chilton R. Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy. World J Cardiol 2021; 13(12): 676-694
- URL: https://www.wjgnet.com/1949-8462/full/v13/i12/676.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i12.676